Cellebrite files Form 144 to sell 5,673 vested RSUs

Cellebrite DI Ltd. submitted a Form 144 reporting proposed sales of Ordinary Shares by an insider.

Rhea-AI Filing Summary

Cellebrite DI Ltd. submitted a Form 144 reporting proposed sales of Ordinary Shares by an insider. The form lists 5,673 Restricted Share Units vested under an S-8 plan (05/20/2026) and shows recent sales by David Gee: 2,609 shares on 02/23/2026, 4,517 shares on 02/24/2026 and 228 shares on 05/12/2026. The filing describes these transactions as employee compensation and restricted‑unit vesting.

Key Figures

RSUs vested: 5,673 shares Sale by David Gee: 2,609 shares Sale by David Gee: 4,517 shares +1 more

4 metrics

RSUs vested 5,673 shares vested under an Issuer S-8 Registered Plan on 05/20/2026

Sale by David Gee 2,609 shares sold on 02/23/2026

Sale by David Gee 4,517 shares sold on 02/24/2026

Sale by David Gee 228 shares sold on 05/12/2026

Key Terms

Restricted Share Units (RSUs), S-8 Registered Plan, Form 144

3 terms

Restricted Share Units (RSUs) financial

"Restricted Share Units Vested Under an Issuer S-8 Registered Plan"

Restricted share units (RSUs) are a form of employee pay where a company promises to give shares (or their cash value) to workers after certain conditions, usually time or performance, are met. For investors, RSUs matter because they can increase the number of shares outstanding and signal how management is being paid and incentivized—think of them as delayed bonuses that convert into ownership when vesting conditions are satisfied.

S-8 Registered Plan regulatory

"Vested Under an Issuer S-8 Registered Plan"

Form 144 regulatory

"Filer Information | Securities To Be Sold | Securities Sold During The Past 3 Months"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Cellebrite (CLBT) report on Form 144?

The filing reports proposed sales of ordinary shares tied to vested RSUs and recent open sales. It lists 5,673 RSUs vested on 05/20/2026 under an S-8 plan and shows three recent share sales by David Gee in Feb–May 2026.

How many Restricted Share Units vested according to the Form 144?

The form shows 5,673 Restricted Share Units vested on 05/20/2026. These vested units are described as issued under an S-8 registered plan and tied to employee compensation.

What recent share sales by David Gee are disclosed in the filing?

The filing discloses three sales by David Gee: 2,609 shares on 02/23/2026, 4,517 shares on 02/24/2026, and 228 shares on 05/12/2026. Each sale includes the share count and transaction date.

Were the vested RSUs sold immediately according to the Form 144?

The filing identifies 5,673 RSUs vested on 05/20/2026 and lists them as securities to be sold, described as employee compensation. The filing does not provide settlement or sale execution timing beyond the vesting date shown.

Under what registration plan were the RSUs issued?

The RSUs are described as vested under an S-8 registered plan. The filing explicitly lists the instrument as "Restricted Share Units Vested Under an Issuer S-8 Registered Plan."

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/21/2026 - 04:25 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001547134
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Cellebrite DI Ltd.
SEC File Number	001-40772
Address of Issuer	94 SHLOMO SHMELZER ROAD PETAH TIKVA ISRAEL 4970602
Phone	972-73-394-8000
Name of Person for Whose Account the Securities are To Be Sold	DAVID GEE
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	OFFICER

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary shares, par value NIS 0.00001	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 38th Floor New York NY 10004	2243	30056.20	250128541	05/21/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary shares, par value NIS 0.00001	05/20/2026	Restricted Share Units Vested Under an Issuer S-8 Registered Plan	Cellebrite DI Ltd.			5673	05/20/2026	Employee compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
David Gee 94 Shlomo Shmelzer Road Petah Tikva L3 4970602	Ordinary shares, par value NIS 0.00001	02/23/2026	2609	32514.59
David Gee 94 Shlomo Shmelzer Road Petah Tikva L3 4970602	Ordinary shares, par value NIS 0.00001	02/24/2026	4517	53932.98
David Gee 94 Shlomo Shmelzer Road Petah Tikva L3 4970602	Ordinary shares, par value NIS 0.00001	05/12/2026	228	2996.58

144: Remarks and Signature

Remarks	The reporting person sold the securities reported herein on 05/21/2026 pursuant to a mandatory, non-discretionary, sell-to-cover arrangement for the purposes of satisfying income tax liabilities incurred upon vesting of restricted share unit awards only.
Date of Notice	05/21/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ David Gee
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)